Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Epidemiology, clinical manifestations, and diagnosis of cryptosporidiosis

Karin Leder, MBBS, FRACP, PhD, MPH, DTMH
Peter F Weller, MD, MACP
Section Editor
Edward T Ryan, MD, DTMH
Deputy Editor
Jennifer Mitty, MD, MPH


Cryptosporidium is an intracellular protozoan parasite that is associated with gastrointestinal diseases in all classes of vertebrates including mammals, reptiles, birds, and fish. Along with Giardia, it is among the most common parasitic enteric pathogens in humans. The organisms infect and reproduce in the epithelial cells of the digestive or respiratory tracts. Infection is predominantly associated with diarrhea and biliary tract disease [1].

This topic will review the epidemiology, clinical manifestations, and diagnosis of cryptosporidiosis. The treatment and prevention of cryptosporidial disease are found elsewhere. (See "Treatment and prevention of cryptosporidiosis".)


Over the last few years molecular methods have enabled characterization and identification of species and genotypes within Cryptosporidium isolates [2]. There are about 20 species of Cryptosporidium, including species that infect mammals, birds, reptiles, and fish [3]. C. parvum (4 mcm diameter) is the main species responsible for clinical disease in humans [4]. C. parvum has been divided into two separate species: C. hominis (previously C. parvum genotype 1) and C. parvum (previously C. parvum genotype 2). C. hominis apparently infects mainly humans, while C. parvum is frequently found in a number of other animals as well as in humans [5,6].

The host range for many species seems to be quite variable, and C. felis, C. muris, C. canis, C. suis, and C. meleagridis have also been identified in some individuals [1,3,7]. Additional heterogeneity within species may lead to variations in infectivity and clinical expression in different hosts [8,9].


Overview — Cryptosporidium was first identified as a cause of gastrointestinal disease in humans in 1976. Cryptosporidium species have been identified in every continent except Antarctica [10], and are now recognized globally as an important cause of diarrhea in both children and adults [11,12]. Cryptosporidium has been described as the etiologic agent in three main epidemiologic scenarios [13]:

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Oct 2017. | This topic last updated: Sep 18, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Chen XM, Keithly JS, Paya CV, LaRusso NF. Cryptosporidiosis. N Engl J Med 2002; 346:1723.
  2. Robinson G, Elwin K, Chalmers RM. Unusual Cryptosporidium genotypes in human cases of diarrhea. Emerg Infect Dis 2008; 14:1800.
  3. Xiao L, Fayer R, Ryan U, Upton SJ. Cryptosporidium taxonomy: recent advances and implications for public health. Clin Microbiol Rev 2004; 17:72.
  4. Fayer R, Ungar BL. Cryptosporidium spp. and cryptosporidiosis. Microbiol Rev 1986; 50:458.
  5. Peng MM, Xiao L, Freeman AR, et al. Genetic polymorphism among Cryptosporidium parvum isolates: evidence of two distinct human transmission cycles. Emerg Infect Dis 1997; 3:567.
  6. Morgan-Ryan UM, Fall A, Ward LA, et al. Cryptosporidium hominis n. sp. (Apicomplexa: Cryptosporidiidae) from Homo sapiens. J Eukaryot Microbiol 2002; 49:433.
  7. Cacciò SM. Molecular epidemiology of human cryptosporidiosis. Parassitologia 2005; 47:185.
  8. Clark DP. New insights into human cryptosporidiosis. Clin Microbiol Rev 1999; 12:554.
  9. Tanriverdi S, Markovics A, Arslan MO, et al. Emergence of distinct genotypes of Cryptosporidium parvum in structured host populations. Appl Environ Microbiol 2006; 72:2507.
  10. O'connor RM, Shaffie R, Kang G, Ward HD. Cryptosporidiosis in patients with HIV/AIDS. AIDS 2011; 25:549.
  11. Yoder JS, Wallace RM, Collier SA, et al. Cryptosporidiosis surveillance--United States, 2009-2010. MMWR Surveill Summ 2012; 61:1.
  12. Kotloff KL, Nataro JP, Blackwelder WC, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 2013; 382:209.
  13. Mor SM, Tzipori S. Cryptosporidiosis in children in Sub-Saharan Africa: a lingering challenge. Clin Infect Dis 2008; 47:915.
  14. Painter JE, Hlavsa MC, Collier SA, et al. Cryptosporidiosis surveillance -- United States, 2011-2012. MMWR Suppl 2015; 64:1.
  15. Guzman-Herrador B, Carlander A, Ethelberg S, et al. Waterborne outbreaks in the Nordic countries, 1998 to 2012. Euro Surveill 2015; 20.
  16. Stensvold CR, Ethelberg S, Hansen L, et al. Cryptosporidium infections in Denmark, 2010-2014. Dan Med J 2015; 62.
  17. McKerr C, Adak GK, Nichols G, et al. An Outbreak of Cryptosporidium parvum across England & Scotland Associated with Consumption of Fresh Pre-Cut Salad Leaves, May 2012. PLoS One 2015; 10:e0125955.
  18. Kuhls TL, Mosier DA, Crawford DL, Griffis J. Seroprevalence of cryptosporidial antibodies during infancy, childhood, and adolescence. Clin Infect Dis 1994; 18:731.
  19. Current WL, Garcia LS. Cryptosporidiosis. Clin Microbiol Rev 1991; 4:325.
  20. Casemore DP. Epidemiological aspects of human cryptosporidiosis. Epidemiol Infect 1990; 104:1.
  21. Jelinek T, Lotze M, Eichenlaub S, et al. Prevalence of infection with Cryptosporidium parvum and Cyclospora cayetanensis among international travellers. Gut 1997; 41:801.
  22. Ungar BL, Gilman RH, Lanata CF, Perez-Schael I. Seroepidemiology of Cryptosporidium infection in two Latin American populations. J Infect Dis 1988; 157:551.
  23. Ungar BL, Mulligan M, Nutman TB. Serologic evidence of Cryptosporidium infection in US volunteers before and during Peace Corps service in Africa. Arch Intern Med 1989; 149:894.
  24. Sewankambo N, Mugerwa RD, Goodgame R, et al. Enteropathic AIDS in Uganda. An endoscopic, histological and microbiological study. AIDS 1987; 1:9.
  25. Colebunders R, Lusakumuni K, Nelson AM, et al. Persistent diarrhoea in Zairian AIDS patients: an endoscopic and histological study. Gut 1988; 29:1687.
  26. Conlon CP, Pinching AJ, Perera CU, et al. HIV-related enteropathy in Zambia: a clinical, microbiological, and histological study. Am J Trop Med Hyg 1990; 42:83.
  27. Laughon BE, Druckman DA, Vernon A, et al. Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. Gastroenterology 1988; 94:984.
  28. Tarimo DS, Killewo JZ, Minjas JN, Msamanga GI. Prevalence of intestinal parasites in adult patients with enteropathic AIDS in north-eastern Tanzania. East Afr Med J 1996; 73:397.
  29. Lengerich EJ, Addiss DG, Marx JJ, et al. Increased exposure to cryptosporidia among dairy farmers in Wisconsin. J Infect Dis 1993; 167:1252.
  30. Soave R, Armstrong D. Cryptosporidium and cryptosporidiosis. Rev Infect Dis 1986; 8:1012.
  31. Mannheimer SB, Soave R. Protozoal infections in patients with AIDS. Cryptosporidiosis, isosporiasis, cyclosporiasis, and microsporidiosis. Infect Dis Clin North Am 1994; 8:483.
  32. Laupland KB, Church DL. Population-based laboratory surveillance for Giardia sp. and Cryptosporidium sp. infections in a large Canadian health region. BMC Infect Dis 2005; 5:72.
  33. Le Moing V, Bissuel F, Costagliola D, et al. Decreased prevalence of intestinal cryptosporidiosis in HIV-infected patients concomitant to the widespread use of protease inhibitors. AIDS 1998; 12:1395.
  34. Framm SR, Soave R. Agents of diarrhea. Med Clin North Am 1997; 81:427.
  35. Yoder JS, Beach MJ, Centers for Disease Control and Prevention (CDC). Cryptosporidiosis surveillance--United States, 2003-2005. MMWR Surveill Summ 2007; 56:1.
  36. Centers for Disease Control and Prevention (CDC). Communitywide cryptosporidiosis outbreak--Utah, 2007. MMWR Morb Mortal Wkly Rep 2008; 57:989.
  37. Newman RD, Sears CL, Moore SR, et al. Longitudinal study of Cryptosporidium infection in children in northeastern Brazil. J Infect Dis 1999; 180:167.
  38. Huang DB, White AC. An updated review on Cryptosporidium and Giardia. Gastroenterol Clin North Am 2006; 35:291.
  39. Davies AP, Chalmers RM. Cryptosporidiosis. BMJ 2009; 339:b4168.
  40. DuPont HL, Chappell CL, Sterling CR, et al. The infectivity of Cryptosporidium parvum in healthy volunteers. N Engl J Med 1995; 332:855.
  41. Chappell CL, Okhuysen PC, Langer-Curry R, et al. Cryptosporidium hominis: experimental challenge of healthy adults. Am J Trop Med Hyg 2006; 75:851.
  42. Chappell CL, Okhuysen PC, Sterling CR, DuPont HL. Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers. J Infect Dis 1996; 173:232.
  43. Jokipii L, Pohjola S, Jokipii AM. Cryptosporidiosis associated with traveling and giardiasis. Gastroenterology 1985; 89:838.
  44. LeChevallier MW, Norton WD, Lee RG. Occurrence of Giardia and Cryptosporidium spp. in surface water supplies. Appl Environ Microbiol 1991; 57:2610.
  45. Juranek DD. Cryptosporidiosis: sources of infection and guidelines for prevention. Clin Infect Dis 1995; 21 Suppl 1:S57.
  46. LeChevallier MW, Norton WD, Lee RG. Giardia and Cryptosporidium spp. in filtered drinking water supplies. Appl Environ Microbiol 1991; 57:2617.
  47. McAnulty JM, Fleming DW, Gonzalez AH. A community-wide outbreak of cryptosporidiosis associated with swimming at a wave pool. JAMA 1994; 272:1597.
  48. Barwick RS, Levy DA, Craun GF, et al. Surveillance for waterborne-disease outbreaks--United States, 1997-1998. MMWR CDC Surveill Summ 2000; 49:1.
  49. Centers for Disease Control and Prevention (CDC). Cryptosporidiosis outbreaks associated with recreational water use--five states, 2006. MMWR Morb Mortal Wkly Rep 2007; 56:729.
  50. Centers for Disease Control and Prevention (CDC). Outbreak of cryptosporidiosis associated with a splash park - Idaho, 2007. MMWR Morb Mortal Wkly Rep 2009; 58:615.
  51. Centers for Disease Control and Prevention (CDC). Outbreak of cryptosporidiosis associated with a firefighting response - Indiana and Michigan, June 2011. MMWR Morb Mortal Wkly Rep 2012; 61:153.
  52. Fricker CR, Crabb JH. Water-borne cryptosporidiosis: detection methods and treatment options. Adv Parasitol 1998; 40:241.
  53. Levy DA, Bens MS, Craun GF, et al. Surveillance for waterborne-disease outbreaks--United States, 1995-1996. MMWR CDC Surveill Summ 1998; 47:1.
  54. MacKenzie WR, Schell WL, Blair KA, et al. Massive outbreak of waterborne cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission. Clin Infect Dis 1995; 21:57.
  55. McDonald AC, Mac Kenzie WR, Addiss DG, et al. Cryptosporidium parvum-specific antibody responses among children residing in Milwaukee during the 1993 waterborne outbreak. J Infect Dis 2001; 183:1373.
  56. Causer LM, Handzel T, Welch P, et al. An outbreak of Cryptosporidium hominis infection at an Illinois recreational waterpark. Epidemiol Infect 2006; 134:147.
  57. DeSilva MB, Schafer S, Kendall Scott M, et al. Communitywide cryptosporidiosis outbreak associated with a surface water-supplied municipal water system--Baker City, Oregon, 2013. Epidemiol Infect 2016; 144:274.
  58. Pönka A, Kotilainen H, Rimhanen-Finne R, et al. A foodborne outbreak due to Cryptosporidium parvum in Helsinki, November 2008. Euro Surveill 2009; 14.
  59. Ethelberg S, Lisby M, Vestergaard LS, et al. A foodborne outbreak of Cryptosporidium hominis infection. Epidemiol Infect 2009; 137:348.
  60. Quiroz ES, Bern C, MacArthur JR, et al. An outbreak of cryptosporidiosis linked to a foodhandler. J Infect Dis 2000; 181:695.
  61. Millard PS, Gensheimer KF, Addiss DG, et al. An outbreak of cryptosporidiosis from fresh-pressed apple cider. JAMA 1994; 272:1592.
  62. From the Centers for Disease Control and Prevention. Outbreaks of Escherichia coli O157:H7 infection and cryptosporidiosis associated with drinking unpasteurized apple cider--Connecticut and New York, October 1996. JAMA 1997; 277:781.
  63. Rosenthal M, Pedersen R, Leibsle S, et al. Notes from the field: cryptosporidiosis associated with consumption of unpasteurized goat milk - Idaho, 2014. MMWR Morb Mortal Wkly Rep 2015; 64:194.
  64. Current WL. Cryptosporidium parvum: household transmission. Ann Intern Med 1994; 120:518.
  65. Musher DM, Musher BL. Contagious acute gastrointestinal infections. N Engl J Med 2004; 351:2417.
  66. Newman RD, Zu SX, Wuhib T, et al. Household epidemiology of Cryptosporidium parvum infection in an urban community in northeast Brazil. Ann Intern Med 1994; 120:500.
  67. Crawford FG, Vermund SH, Ma JY, Deckelbaum RJ. Asymptomatic cryptosporidiosis in a New York City day care center. Pediatr Infect Dis J 1988; 7:806.
  68. Drinkard LN, Halbritter A, Nguyen GT, et al. Notes from the Field: Outbreak of Cryptosporidiosis Among Veterinary Medicine Students--Philadelphia, Pennsylvania, February 2015. MMWR Morb Mortal Wkly Rep 2015; 64:773.
  69. Webb LM, Tubach SA, Hunt DC, Centers for Disease Control and Prevention (CDC). Outbreak of cryptosporidiosis among responders to a rollover of a truck carrying calves - Kansas, April 2013. MMWR Morb Mortal Wkly Rep 2014; 63:1185.
  70. Su CP, Stover DT, Buss BF, et al. Occupational Animal Exposure Among Persons with Campylobacteriosis and Cryptosporidiosis - Nebraska, 2005-2015. MMWR Morb Mortal Wkly Rep 2017; 66:955.
  71. Mor SM, Tumwine JK, Ndeezi G, et al. Respiratory cryptosporidiosis in HIV-seronegative children in Uganda: potential for respiratory transmission. Clin Infect Dis 2010; 50:1366.
  72. Lendner M, Daugschies A. Cryptosporidium infections: molecular advances. Parasitology 2014; 141:1511.
  73. Kirkpatrick BD, Noel F, Rouzier PD, et al. Childhood cryptosporidiosis is associated with a persistent systemic inflammatory response. Clin Infect Dis 2006; 43:604.
  74. Heyworth MF. Parasitic diseases in immunocompromised hosts. Cryptosporidiosis, isosporiasis, and strongyloidiasis. Gastroenterol Clin North Am 1996; 25:691.
  75. Genta RM, Chappell CL, White AC Jr, et al. Duodenal morphology and intensity of infection in AIDS-related intestinal cryptosporidiosis. Gastroenterology 1993; 105:1769.
  76. Petersen C. Cryptosporidium and the food supply. Lancet 1995; 345:1128.
  77. Okhuysen PC, Chappell CL, Sterling CR, et al. Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum. Infect Immun 1998; 66:441.
  78. Benhamou Y, Kapel N, Hoang C, et al. Inefficacy of intestinal secretory immune response to Cryptosporidium in acquired immunodeficiency syndrome. Gastroenterology 1995; 108:627.
  79. Cozon G, Biron F, Jeannin M, et al. Secretory IgA antibodies to Cryptosporidium parvum in AIDS patients with chronic cryptosporidiosis. J Infect Dis 1994; 169:696.
  80. Rehg JE. Effect of interferon-gamma in experimental Cryptosporidium parvum infection. J Infect Dis 1996; 174:229.
  81. Culshaw RJ, Bancroft GJ, McDonald V. Gut intraepithelial lymphocytes induce immunity against Cryptosporidium infection through a mechanism involving gamma interferon production. Infect Immun 1997; 65:3074.
  82. Gomez Morales MA, Ausiello CM, Guarino A, et al. Severe, protracted intestinal cryptosporidiosis associated with interferon gamma deficiency: pediatric case report. Clin Infect Dis 1996; 22:848.
  83. Tilley M, McDonald V, Bancroft GJ. Resolution of cryptosporidial infection in mice correlates with parasite-specific lymphocyte proliferation associated with both Th1 and Th2 cytokine secretion. Parasite Immunol 1995; 17:459.
  84. Janoff EN, Limas C, Gebhard RL, Penley KA. Cryptosporidial carriage without symptoms in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1990; 112:75.
  85. Mor SM, DeMaria A Jr, Griffiths JK, Naumova EN. Cryptosporidiosis in the elderly population of the United States. Clin Infect Dis 2009; 48:698.
  86. Jokipii L, Jokipii AM. Timing of symptoms and oocyst excretion in human cryptosporidiosis. N Engl J Med 1986; 315:1643.
  87. Checkley W, Epstein LD, Gilman RH, et al. Effects of Cryptosporidium parvum infection in Peruvian children: growth faltering and subsequent catch-up growth. Am J Epidemiol 1998; 148:497.
  88. Cama VA, Ross JM, Crawford S, et al. Differences in clinical manifestations among Cryptosporidium species and subtypes in HIV-infected persons. J Infect Dis 2007; 196:684.
  89. Gross TL, Wheat J, Bartlett M, O'Connor KW. AIDS and multiple system involvement with cryptosporidium. Am J Gastroenterol 1986; 81:456.
  90. Soave R, Johnson WD Jr. Cryptosporidium and Isospora belli infections. J Infect Dis 1988; 157:225.
  91. Moore JA, Frenkel JK. Respiratory and enteric cryptosporidiosis in humans. Arch Pathol Lab Med 1991; 115:1160.
  92. Travis WD, Schmidt K, MacLowry JD, et al. Respiratory cryptosporidiosis in a patient with malignant lymphoma. Report of a case and review of the literature. Arch Pathol Lab Med 1990; 114:519.
  93. Meynard JL, Meyohas MC, Binet D, et al. Pulmonary cryptosporidiosis in the acquired immunodeficiency syndrome. Infection 1996; 24:328.
  94. Clavel A, Arnal AC, Sánchez EC, et al. Respiratory cryptosporidiosis: case series and review of the literature. Infection 1996; 24:341.
  95. Blanshard C, Jackson AM, Shanson DC, et al. Cryptosporidiosis in HIV-seropositive patients. Q J Med 1992; 85:813.
  96. Van Lint P, Rossen JW, Vermeiren S, et al. Detection of Giardia lamblia, Cryptosporidium spp. and Entamoeba histolytica in clinical stool samples by using multiplex real-time PCR after automated DNA isolation. Acta Clin Belg 2013; 68:188.
  97. Morgan UM, Pallant L, Dwyer BW, et al. Comparison of PCR and microscopy for detection of Cryptosporidium parvum in human fecal specimens: clinical trial. J Clin Microbiol 1998; 36:995.
  98. Weber R, Bryan RT, Bishop HS, et al. Threshold of detection of Cryptosporidium oocysts in human stool specimens: evidence for low sensitivity of current diagnostic methods. J Clin Microbiol 1991; 29:1323.
  99. Garcia LS, Brewer TC, Bruckner DA. Fluorescence detection of Cryptosporidium oocysts in human fecal specimens by using monoclonal antibodies. J Clin Microbiol 1987; 25:119.
  100. Kehl KS, Cicirello H, Havens PL. Comparison of four different methods for detection of Cryptosporidium species. J Clin Microbiol 1995; 33:416.
  101. Arrowood MJ, Sterling CR. Comparison of conventional staining methods and monoclonal antibody-based methods for Cryptosporidium oocyst detection. J Clin Microbiol 1989; 27:1490.
  102. McHardy IH, Wu M, Shimizu-Cohen R, et al. Detection of intestinal protozoa in the clinical laboratory. J Clin Microbiol 2014; 52:712.
  103. Parisi MT, Tierno PM Jr. Evaluation of new rapid commercial enzyme immunoassay for detection of Cryptosporidium oocysts in untreated stool specimens. J Clin Microbiol 1995; 33:1963.
  104. Garcia LS, Shimizu RY. Evaluation of nine immunoassay kits (enzyme immunoassay and direct fluorescence) for detection of Giardia lamblia and Cryptosporidium parvum in human fecal specimens. J Clin Microbiol 1997; 35:1526.
  105. Aarnaes SL, Blanding J, Speier S, et al. Comparison of the ProSpecT and Color Vue enzyme-linked immunoassays for the detection of Cryptosporidium in stool specimens. Diagn Microbiol Infect Dis 1994; 19:221.
  106. Siddons CA, Chapman PA, Rush BA. Evaluation of an enzyme immunoassay kit for detecting cryptosporidium in faeces and environmental samples. J Clin Pathol 1992; 45:479.
  107. Dagan R, Fraser D, El-On J, et al. Evaluation of an enzyme immunoassay for the detection of Cryptosporidium spp. in stool specimens from infants and young children in field studies. Am J Trop Med Hyg 1995; 52:134.